INZY

Inozyme Pharma
INZY

Overview Fund Activity
Delisted

INZY was delisted on the 30th of June, 2025.

Back to rankings

90 hedge funds and large institutions have $240M invested in Inozyme Pharma in 2024 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 38 increasing their positions, 20 reducing their positions, and 19 closing their positions.

Holders
90
Holders Change
+1
Holders Change %
+1.12%
% of All Funds
1.31%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
20
Increased
38
Reduced
20
Closed
19
Calls
$80K
Puts
$19K
Net Calls
+$61K
Net Calls Change
+$262K

Top Buyers

1
SVCM
1
Saturn V Capital Management
Texas
$5.09M
2
Millennium Management
2
Millennium Management
New York
$7.97M
3
EAM
3
Eventide Asset Management
Massachusetts
$17.6M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$11M
5
SC
5
Samlyn Capital
New York
$14.9M

Top Sellers

1
KCM
1
Kennedy Capital Management
Missouri
$0
2
EAM
2
Exome Asset Management
New York
$0
3
PHP
3
Parkman Healthcare Partners
Connecticut
$0
4
LCM
4
Laurion Capital Management
New York
$564K
5
SCM
5
Superstring Capital Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
BCM
101
Bridgeway Capital Management
Texas
– -$136K -17,800 Closed
Lido Advisors
102
Lido Advisors
California
– -$131K -17,108 Closed
SG Americas Securities
103
SG Americas Securities
New York
– -$107K -13,926 Closed
MLICM
104
Metropolitan Life Insurance Company (MetLife)
New York
– -$20.9K -2,728 Closed
EC
105
EntryPoint Capital
New York
– -$11.2K -1,460 Closed
S
106
SignatureFD
Georgia
– -$866 -113 Closed
IGWM
107
ICA Group Wealth Management
Colorado
– -$651 -85 Closed
AWM
108
Avior Wealth Management
Nebraska
– -$68 -9 Closed
1 2 3 4
5